| Bharat Parenterals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 541096 |
NSE Symbol : - |
P/E(TTM) : 62.86 |
|
ISIN Demat : INE365Y01019 |
Div & Yield% : 0.07 |
EPS(TTM) : 23.24 |
|
Book Value(₹) : 583.78 |
Market Cap(₹Cr) : 1,006.78 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 55.50 | 56.54 | 41.41 | 41.70 | 94.37 | 80.28 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 55.50 | 56.54 | 41.41 | 41.70 | 94.37 | 80.28 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.05 | 4.44 | 2.28 | 4.21 | 1.62 | 2.26 |
| Total Income | 56.55 | 60.98 | 43.69 | 45.91 | 95.99 | 82.54 |
| Total Expenditure | 48.68 | 56.50 | 37.94 | 39.37 | 79.11 | 75.69 |
| PBIDT | 7.88 | 4.48 | 5.75 | 6.54 | 16.88 | 6.85 |
| Interest | 0.69 | 0.51 | 0.55 | 0.96 | 1.42 | 1.48 |
| PBDT | 7.19 | 3.96 | 5.20 | 5.59 | 15.46 | 5.38 |
| Depreciation | 2.26 | 2.04 | 2.10 | 2.17 | 2.06 | 1.82 |
| Tax | 1.57 | 0.99 | 1.12 | 1.14 | 3.70 | 1.33 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.29 | -0.44 | 0.06 | -0.45 | -0.30 | -0.05 |
| Reported Profit After Tax | 3.66 | 1.38 | 1.92 | 2.73 | 10.00 | 2.28 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 3.66 | 1.38 | 1.92 | 2.73 | 10.00 | 2.28 |
| EPS (Unit Curr.) | 5.31 | 2.00 | 2.78 | 3.96 | 14.51 | 3.48 |
| EPS (Adj) (Unit Curr.) | 5.31 | 2.00 | 2.78 | 3.96 | 14.51 | 3.48 |
| Calculated EPS (Unit Curr.) | 5.31 | 2.00 | 2.78 | 3.96 | 14.51 | 3.31 |
| Calculated EPS (Adj) (Unit Curr.) | 5.31 | 2.00 | 2.78 | 3.96 | 14.51 | 3.31 |
| Calculated EPS (Ann.) (Unit Curr.) | 21.23 | 7.99 | 11.12 | 15.83 | 58.04 | 13.25 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 21.23 | 7.99 | 11.12 | 15.83 | 58.04 | 13.25 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.89 | 6.89 | 6.89 | 6.89 | 6.89 | 6.89 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 14.20 | 7.92 | 13.89 | 15.68 | 17.89 | 8.53 |
| PBDTM(%) | 12.95 | 7.00 | 12.56 | 13.41 | 16.38 | 6.70 |
| PATM(%) | 6.59 | 2.44 | 4.64 | 6.55 | 10.60 | 2.84 |
